Biocept, Inc.

BIOC | $0.4349 -10.32% 750K

(0.0% 1d) (0.0% 1m) (22.1% 1y) (0.0% 2d) (0.0% 3d) (-13.1% 7d) (-9.6% volume)
Earnings Calendar: 2023-04-17
Market Cap: $ 1,142,059
http://www.biocept.com
Sec Filling | Patents | 88 employees

(US) Biocept, Inc. is an oncology laboratory service company, which focuses on the development and marketing of novel laboratory products in the detection of rare cells to include circulating tumor cells. It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA tests utilizing a standard blood sample. The company utilizes cell enrichment and extraction technology for the detection and analysis of circulating tumor DNA tests. It also offers services to other laboratory testing providers, academic institutions, research organizations, biopharmaceutical companies and clinical trial support and specific oncogenic alterations. Biocept was founded on May 12, 1997 and is headquartered in San Diego, CA.

tumor cells t-cell clinical trials ceiling

add to watch list Paper trade email alert is off

Syneos Health, Inc.

SYNH | $42.98 0.0% 7.4M

Health Services

(0.0% 1d) (0.0% 1m) (8.6% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (107.31% volume)
Earnings Calendar: 2023-11-02
Market Cap: $ 4,457,850,313
http://www.syneoshealth.com
Sec Filling | Patents | 24000 employees

(US) Syneos Health, Inc. provides outsourced clinical development and commercialization services to biopharmaceutical companies. It operates through the following business segments: Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers clinical development services spanning Phase I to Phase IV, including global studies, as well as unbundled service offerings such as clinical monitoring, investigator recruitment, patient recruitment, data management, and study startup to assist customers with their drug development process. The Commercial Solutions segment provides commercialization services, including outsourced field selling solutions, medication adherence, communications, and consulting services. The company was founded in 1998 and is headquartered in Morrisville, NC.

communication

add to watch list Paper trade email alert is off

The Joint Corp.

JYNT | News | $11.9 -1.0% -1.01% 72K

Health Services

(0.0% 1d) (-8.2% 1m) (-25.2% 1y) (0.0% 2d) (0.2% 3d) (-1.1% 7d) (NaN% volume)
Earnings Calendar: 2024-03-07
Market Cap: $ 175,837,292
http://www.thejoint.com
Sec Filling | Patents | 150 employees

The Joint Corp. (United States) engages in the development, ownership, operation, support and management of chiropractic clinics. It operates through two segments: Corporate Clinics and Franchise Operations. The Corporate Clinics segment comprises of the operating activities of the company owned or managed clinics. The Franchise Operations segment includes the operating activities of the franchise business unit. The Joint was founded by Fred Gerretzen, Charles Barnwell, John Leonesio, Todd Welker, Barbara Holland, Steven P. Colmar, Craig P. Colmar and Richard Rees on March 10, 2010 and is headquartered in Scottsdale, AZ.

add to watch list Paper trade email alert is off